• Publications
  • Influence
Consensus statement on chronic and subacute high altitude diseases.
This is an international consensus statement of an ad hoc committee formed by the International Society for Mountain Medicine (ISMM) at the VI World Congress on Mountain Medicine and High AltitudeExpand
  • 302
  • 21
Clinical review: Update on hemodynamic monitoring - a consensus of 16
Hemodynamic monitoring plays a fundamental role in the management of acutely ill patients. With increased concerns about the use of invasive techniques, notably the pulmonary artery catheter, toExpand
  • 276
  • 18
Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes.
OBJECTIVES We sought to assess the mechanism and prognostic value of elevated troponins in patients without acute coronary syndromes (ACS). BACKGROUND Cardiac troponins are used as specific markersExpand
  • 346
  • 16
Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema
Context Very few trials have evaluated ways to prevent high-altitude pulmonary edema (HAPE). Contribution In this double-blind trial, 29 adults with a history of HAPE were randomly assigned toExpand
  • 234
  • 15
Prevalence of acute mountain sickness in the Swiss Alps.
OBJECTIVE--To assess the prevalence of symptoms and signs of acute mountain sickness of the Swiss Alps. DESIGN--A study using an interview and clinical examination in a representative population ofExpand
  • 276
  • 10
Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness.
A possible contribution of exercise to the fluid retention associated with acute mountain sickness (AMS) was investigated in 17 mountaineers who underwent an exercise test for 30 min on a bicycleExpand
  • 84
  • 8
High altitude-induced pulmonary oedema.
Almost one mountain trekker or climber out of two develops several symptoms of high altitude illness after a rapid ascent (> 300 m/day) to an altitude above 4000 m. Individual susceptibility is theExpand
  • 96
  • 7
High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary Pressure
BackgroundHigh-altitude pulmonary edema (HAPE) is characterized by severe pulmonary hypertension and bronchoalveolar lavage fluid changes indicative of inflammation. It is not known, however, whetherExpand
  • 279
  • 6
Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor.
CONTEXT The pathogenesis of high-altitude pulmonary edema (HAPE) is considered an altered permeability of the alveolar-capillary barrier secondary to intense pulmonary vasoconstriction and highExpand
  • 282
  • 6
Prevention and treatment of high-altitude pulmonary edema.
  • M. Maggiorini
  • Medicine
  • Progress in cardiovascular diseases
  • 1 May 2010
We distinguish two forms of high altitude illness, a cerebral form called acute mountain sickness and a pulmonary form called high-altitude pulmonary edema (HAPE). Individual susceptibility is theExpand
  • 73
  • 6